Black Rock Inc. Shattuck Labs, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,474,477 shares of STTK stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,474,477
Previous 529,513
367.31%
Holding current value
$1.98 Million
Previous $4.73 Million
101.8%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding STTK
# of Institutions
76Shares Held
30.9MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$5.31 Million2.25% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$4.43 Million0.55% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$3.74 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.4MShares$1.92 Million0.0% of portfolio
-
Clark Estates Inc New York, NY1.48MShares$1.18 Million0.4% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $33.9M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...